Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vancomycin-resistant enterococci.

Y Cetinkaya1, P Falk, C G Mayhall

  • 1Department of Healthcare Epidemiology and Division of Infectious Diseases, University of Texas Medical Branch at Galveston, Galveston, Texas 77555-0835, USA.

Clinical Microbiology Reviews
|October 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Similar collagen distribution in full-thickness skin grafts in intraperitoneal and onlay positions, an experimental mice-study.

Hernia : the journal of hernias and abdominal wall surgery·2022
Same author

Similar collagen distribution in full-thickness skin grafts in intraperitoneal and onlay positions, an experimental mice-study.

Hernia : the journal of hernias and abdominal wall surgery·2022
Same author

Results at 3-year follow-up of totally extraperitoneal (TEP) hernia surgery with long-term resorbable mesh.

Hernia : the journal of hernias and abdominal wall surgery·2020
Same author

Giant ventral hernia-relationship between abdominal wall muscle strength and hernia area.

BMC surgery·2016
Same author

Effect of a DACC dressing on the growth properties and proliferation rate of cultured fibroblasts.

Journal of wound care·2012
Same author

Local and systemic expressions of MMP-9, TIMP-1 and PAI-1 in patients undergoing surgery for clinically suspected appendicitis.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes·2012
Same journal

Diagnostic challenges in re-emerging rickettsioses: why current tools fall short.

Clinical microbiology reviews·2026
Same journal

Current progress in developing mRNA-lipid nanoparticle vaccines against human bacterial pathogens.

Clinical microbiology reviews·2026
Same journal

The gut microbiome and colorectal cancer.

Clinical microbiology reviews·2026
Same journal

Influence of fungi on epithelial homeostasis and role in inflammatory diseases.

Clinical microbiology reviews·2026
Same journal

Coxsackievirus A6 on the rise: epidemiology, pathogenicity, evolutionary dynamics, and antiviral strategy.

Clinical microbiology reviews·2026
Same journal

Intravesical therapies for catheter-associated urinary tract infections: current approaches and future directions.

Clinical microbiology reviews·2026
See all related articles

Vancomycin-resistant enterococci (VRE) are a growing threat due to antibiotic resistance. Understanding VRE history, resistance, and spread is crucial for effective control and treatment strategies.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Vancomycin-resistant enterococci (VRE) emerged in the mid-1980s and have become a significant nosocomial pathogen.
  • VRE possess intrinsic resistance and acquire new resistance mechanisms, conferring a selective advantage in the gut microbiome.
  • The potential for VRE to transfer resistance genes to other bacteria, like Staphylococcus aureus, is a major public health concern.

Purpose of the Study:

  • To provide a comprehensive review of vancomycin-resistant enterococci (VRE).
  • To discuss the history, epidemiology, and mechanisms of VRE resistance.
  • To outline current control measures and treatment options for VRE infections.

Main Methods:

  • Literature review of VRE history, resistance mechanisms, epidemiology, and clinical management.

Related Experiment Videos

  • Synthesis of data on VRE spread and therapeutic challenges.
  • Analysis of VRE control strategies and treatment efficacy.

    • Main Results:

    • VRE have demonstrated rapid global dissemination since their identification.
    • Multiple mechanisms contribute to VRE resistance, including intrinsic and acquired resistance genes.
    • VRE pose a significant therapeutic challenge due to limited treatment options and the risk of further resistance spread.

    Conclusions:

    • VRE represent a critical challenge in healthcare settings, necessitating robust infection control.
    • Continued surveillance and research into novel therapeutic approaches are essential for managing VRE.
    • Preventing the transfer of vancomycin resistance is vital to avert the emergence of pan-resistant pathogens.